Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.

about

Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice.

P2860

Q47159679-401AB109-7AD7-4285-9DE3-CDE36144FACA

P2860

Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.

Item

http://www.wikidata.org/entity/Q38825796

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cutting Edge: A Dual TLR2 and ...... ell-Mediated Immune Responses.

@en

type

Item

label

Cutting Edge: A Dual TLR2 and ...... ell-Mediated Immune Responses.

@en

prefLabel

Cutting Edge: A Dual TLR2 and ...... ell-Mediated Immune Responses.

@en

P1476

Cutting Edge: A Dual TLR2 and ...... Cell-Mediated Immune Responses

@en

P2093

Alain Lamoureux

http://www.w3.org/2001/XMLSchema#string

Alice Gutjahr

http://www.w3.org/2001/XMLSchema#string

Emma Gostick

http://www.w3.org/2001/XMLSchema#string

Fabienne Vernejoul

http://www.w3.org/2001/XMLSchema#string

Gérard Tiraby

http://www.w3.org/2001/XMLSchema#string

Thierry Lioux

http://www.w3.org/2001/XMLSchema#string

Victor Appay

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond oxidative stress: an immunologist's guide to reactive oxygen species

Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting

Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses

Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.

Germinal centers.

Neonatal Fc receptor: from immunity to therapeutics

Vaccine adjuvants: putting innate immunity to work.

CXCL13 is a plasma biomarker of germinal center activity.

Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.

P304

4205-4209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1602131

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28432147

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.

about

P2860

P2860

Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921